Found 6 matching trials
Adjuvant Therapy of Ensartinib in Stage IB-IIIA ALK-positive Non-small Cell Lung Cancer
PHASE2This is a prospective, multi-center, single-arm, phase 2 study aiming to as...
Efficacy and Safety of Ensartinib Combined With Anlotinib in Lorlatinib-Resistant ALK-Positive NSCLC
PHASE4ALK TKIs, particularly second- and third-generation ALK TKIs, have signific...
Location
Multiple Locations
Ensartinib as Adjuvant Treatment in Anaplastic Lymphoma Kinase (ALK) Positive Non-small Cell Lung Cancer
PHASE3This double-blind, randomized, placebo-controlled, multicenter, Phase III s...
Location
TianJin Medical University Cancer Institute & Hospital
Ensatinib Treat Second-generation ALK-TKI Resistance After Second-generation ALK-TKI Resistance
PHASE2After the use of second-generation ALK-TKI drug resistance, about 50% of ti...
Location
Sun Yat-sen University
Ensatinib in alK-positive Patients Undergoing Initial Treatment for Advanced Non-small Cell Lung Cancer
N/AThe experimental design is exploratory, single-arm, multi-center, real-worl...
Location
Beijing Cancer Hospital
A Study Comparing Ensatinib Versus Platinum-Based Chemotherapy as Adjuvant Treatment for Stage II-IIIA ALK -Positive Non-Small Cell Lung Cancer
PHASE2This randomized, active-controlled, multicenter, open-label, Phase II study...
Location
Multiple Locations